Semaglutide vials briefing
Product name:Semaglutide
Cas No.:910463-68-2
Molecular formular: C187H291N45O59
Molecular weight : 4113.58
Purity: 99%
Appearance:White Crystalline Powder
Semaglutide (USAN; trade name Oze mpic) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Oze mpic. As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production.It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed in 2016. FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour. It can be used as both injection-type or oral-type drug.
Researchers at the University of Leeds reported in 2017 that it can also be used for the treatment of obesity. It reduces hunger, food craving and body fat.
Related Products
| Semaglutide | Vial package | 5mg 10mg 15mg |
| Tirzepatide | Vial package | 5mg 10mg 15mg |
| Retatrutide | Vial package | 5mg 10mg 15mg |
zoritoler imol –
Definitely consider that that you said. Your favourite reason appeared to be on the web the simplest thing to take note of. I say to you, I certainly get irked at the same time as other folks think about issues that they just don’t recognize about. You controlled to hit the nail upon the highest as smartly as defined out the whole thing without having side effect , folks can take a signal. Will likely be again to get more. Thanks
zoritoler imol –
Perfectly indited subject material, thankyou for selective information.